When Will Male Birth Control Be Available? (2026 Update)
Published October 23, 2026 · Investigational · Not approved
The short answer: not yet, and no one can responsibly promise a date. As of October 2026, no male contraceptive pill, gel or implant has been approved by the FDA or any other regulator. But more candidates are in human trials now than at almost any point in history.
How a contraceptive reaches pharmacies
New drugs typically move through Phase 1 (safety in small groups), Phase 2 (dosing and early effectiveness) and Phase 3 (large studies to confirm effectiveness and safety) before a company can apply for approval. Each stage can take years, and many candidates stop along the way.
The front-runner by stage: NES/T gel
NES/T is a daily hormonal gel rubbed onto the shoulders. It was developed by the Population Council with the U.S. National Institute of Child Health and Human Development (NICHD), and Contraline now holds worldwide rights. In June 2026 Contraline said NES/T had completed a global Phase 2b trial enrolling 462 couples and that it anticipates starting Phase 3 in 2027 [1]. In 2022 an NICHD researcher noted that even after a successful Phase 3, bringing the product to market could take years more [2].
The pill: YCT-529
YCT-529, from YourChoice Therapeutics, is a non-hormonal daily pill. A first-in-human Phase 1a study in 16 men completed in June 2024, and the published results reported single doses were well tolerated [3][4]. A Phase 1b/2a study testing daily dosing for up to 180 days is listed as recruiting in New Zealand [5]. That's earlier in the pipeline than NES/T.
So what's a realistic expectation?
Because Phase 3 for NES/T hadn't started as of this update, any approval is at least several years away, and that's if trials succeed. We'll update this page as companies and registries publish new information.
What you can do now
Today's male options are condoms and vasectomy. If you want to hear when there's real news, join our free update list.